Clinical Trials
3 trialsNCT05177211 2026-04-17
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT03952039 2025-08-28
FREEDOM2
Celgene
Phase 3 Completed
NCT03755518 2024-12-12
FREEDOM
Celgene
Phase 3 Terminated